These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36965745)

  • 1. Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
    Karimi-Haghighi S; Mahmoudi M; Sayehmiri F; Mozafari R; Haghparast A
    Eur J Pharmacol; 2023 Jul; 951():175669. PubMed ID: 36965745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cannabinoid CB₁ receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice.
    Yu LL; Zhou SJ; Wang XY; Liu JF; Xue YX; Jiang W; Lu L
    Behav Brain Res; 2011 Feb; 217(1):111-6. PubMed ID: 20937331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses.
    Gobira PH; Joca SR; Moreira FA
    Acta Neuropsychiatr; 2024 Apr; 36(2):67-77. PubMed ID: 35993329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CB1 receptors in psychostimulant addiction.
    Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ
    Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
    Nawata Y; Kitaichi K; Yamamoto T
    Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.
    Anggadiredja K; Nakamichi M; Hiranita T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
    Neuropsychopharmacology; 2004 Aug; 29(8):1470-8. PubMed ID: 15085091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice.
    Lopes JB; Bastos JR; Costa RB; Aguiar DC; Moreira FA
    Psychopharmacology (Berl); 2020 Feb; 237(2):385-394. PubMed ID: 31667531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.
    Xi ZX; Gardner EL
    Curr Drug Abuse Rev; 2008 Nov; 1(3):303-27. PubMed ID: 19430578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
    Ebrahimi-Ghiri M; Khakpai F; Zarrindast MR
    J Psychopharmacol; 2021 Jul; 35(7):875-884. PubMed ID: 33155516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
    Downey LA; Loftis JM
    Eur J Pharmacol; 2014 Mar; 727():125-9. PubMed ID: 24485894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
    Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.
    Neisewander JL; Cheung TH; Pentkowski NS
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):301-19. PubMed ID: 23973315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.
    Vinklerová J; Nováková J; Sulcová A
    J Psychopharmacol; 2002 Jun; 16(2):139-43. PubMed ID: 12095072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and antinociceptive effects of different psychostimulant drugs in prenatally methamphetamine-exposed rats.
    Yamamotová A; Šlamberová R
    Physiol Res; 2012; 61(Suppl 2):S139-47. PubMed ID: 23130899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
    Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
    Harvey EL; Baker LE
    Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.
    Morra JT; Glick SD; Cheer JF
    Neuropharmacology; 2012 Sep; 63(4):565-74. PubMed ID: 22609048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.
    Jing L; Qiu Y; Zhang Y; Li JX
    Drug Alcohol Depend; 2014 Oct; 143():251-6. PubMed ID: 25169627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine- and cocaine-triggered methamphetamine reinstatement in female and male Sprague-Dawley rats.
    Pittenger ST; Chou S; Barrett ST; Catalano I; Lydiatt M; Bevins RA
    Pharmacol Biochem Behav; 2017 Aug; 159():69-75. PubMed ID: 28712749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
    Dolan SB; Forster MJ; Gatch MB
    Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.